SCHEMBL9168399

SCHEMBL9168399

CCCCCCCCCCCCCCCCCCOc1cc(N)cc(C(N)=O)c1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.60
TSHR P16473 2/20 0.53
TP53 P04637 2/20 0.49
SMPD1 P17405 3/20 0.48
PLA2G4B P0C869 1/20 0.48
BLM P54132 1/20 0.47
NPC1 O15118 2/20 0.47
MAPT P10636 2/20 0.47
RAB9A P51151 2/20 0.47
ALDH1A1 P00352 1/20 0.47
RARB P10826 3/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL203212 1.00 PLA2G2A (0.60) PLA2G2ATSHRTP53SMPD1PLA2G4B
SCHEMBL5086980 0.91 PLA2G2A (0.73) PLA2G2ATSHRTP53SMPD1PLA2G4B
SCHEMBL11695455 0.91 PLA2G2A (0.73) PLA2G2ATSHRTP53SMPD1PLA2G4B
SCHEMBL14763514 0.91 PLA2G2A (0.73) PLA2G2ATSHRTP53SMPD1PLA2G4B
Hydrochloric Acid SCHEMBL5005668 0.89 PLA2G2A (0.71) PLA2G2ATSHRTP53SMPD1PLA2G4B
SCHEMBL9168136 0.85 PLA2G2A (0.57) PLA2G2ATSHRTP53SMPD1PLA2G4B
SCHEMBL17414620 0.84 PLA2G2A (0.62) PLA2G2ATSHRTP53PLA2G4BBLM
SCHEMBL15977059 0.84 PLA2G2A (0.57) PLA2G2ATSHRTP53PLA2G4BNPC1
SCHEMBL201440 0.84 PLA2G2A (0.59) PLA2G2ATSHRTP53SMPD1PLA2G4B
SCHEMBL12709821 0.82 TSHR (0.68) PLA2G2ATSHRTP53PLA2G4BBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5446189-A Diester intermediates for diacid enzyme inhibitor HOFFMANN-LA ROCHE INC. (US) 1995-08-29 US disclosed
US-5324747-A Treatment of inflammatory diseases HOFFMANN-LA ROCHE INC. (US) 1994-06-28 US disclosed
EP-0579066-A2 N-substituted anilines F. HOFFMANN-LA ROCHE AG (CH) 1994-01-19 EP disclosed